Lista de obras -

A Multi-Vector, Multi-Envelope HIV-1 Vaccine

artículo científico publicado en 2007

A rodent model of traumatic stress induces lasting sleep and quantitative electroencephalographic disturbances

artículo científico publicado en 2015

CD8+ T-cells: are they sufficient to prevent, contain or eradicate HIV-1 infection?

artículo científico publicado en 2005

Clade, Country and Region-specific HIV-1 Vaccines: Are they necessary?

artículo científico publicado en 2005

Clustering of Th Cell Epitopes on Exposed Regions of HIV Envelope Despite Defects in Antibody Activity ⬇️

artículo científico publicado el 15 de octubre de 2003

Discovery and Optimization of Potent and CNS Penetrant M5-Preferring Positive Allosteric Modulators Derived from a Novel, Chiral N-(Indanyl)piperidine Amide Scaffold

artículo científico publicado en 2018

Discovery and optimization of 3-(4-aryl/heteroarylsulfonyl)piperazin-1-yl)-6-(piperidin-1-yl)pyridazines as novel, CNS penetrant pan-muscarinic antagonists.

artículo científico publicado en 2017

Discovery of a novel 2,4-dimethylquinoline-6-carboxamide M4 positive allosteric modulator (PAM) chemotype via scaffold hopping

artículo científico publicado en 2017

Discovery of a novel, CNS penetrant M4 PAM chemotype based on a 6-fluoro-4-(piperidin-1-yl)quinoline-3-carbonitrile core

artículo científico publicado en 2017

Epstein-Barr virus vaccine development: a lytic and latent protein cocktail

artículo científico publicado en 2008

Genetic analyses of gene function and pathogenesis of murine cytomegalovirus by transposon-mediated mutagenesis

artículo científico publicado en 2002

Gle1 functions during mRNA export in an oligomeric complex that is altered in human disease

artículo científico publicado en 2013

HIV vaccine rationale, design and testing.

artículo científico publicado en 2005

HIV vaccines: brief review and discussion of future directions.

artículo científico publicado en 2005

HIV-1 envelope T cell epitope "hotspots " among mice and humans and among CD4+ and CD8+ T cell subpopulations

artículo científico publicado en 2007

HIV-1 vaccine development: tackling virus diversity with a multi-envelope cocktail.

artículo científico publicado en 2008

Human PIV-2 recombinant Sendai virus (rSeV) elicits durable immunity and combines with two additional rSeVs to protect against hPIV-1, hPIV-2, hPIV-3, and RSV.

artículo científico publicado en 2009

In vitro and in vivo characterization of a murine cytomegalovirus with a mutation at open reading frame m166.

artículo científico publicado en 2003

Inhibition of ex vivo-expanded cytotoxic T-lymphocyte function by high-dose cyclosporine

artículo científico publicado en 2003

Minor components of a multi-envelope HIV vaccine are recognized by type-specific T-helper cells

artículo científico publicado en 2004

Multi-envelope HIV-1 vaccine devoid of SIV components controls disease in macaques challenged with heterologous pathogenic SHIV.

artículo científico publicado en 2005

Multiple mycobacterial antigens are targets of the adaptive immune response in pulmonary sarcoidosis ⬇️

artículo científico publicado el 23 de noviembre de 2010

Murine cytomegalovirus with a transposon insertional mutation at open reading frame M35 is defective in growth in vivo

artículo científico publicado en 2003

Murine cytomegalovirus with a transposon insertional mutation at open reading frame m155 is deficient in growth and virulence in mice

artículo científico publicado en 2004

Partial mGlu₅ Negative Allosteric Modulators Attenuate Cocaine-Mediated Behaviors and Lack Psychotomimetic-Like Effects

artículo científico publicado en 2015

Recombinant Sendai virus as a novel vaccine candidate for respiratory syncytial virus

artículo científico publicado en 2005

Recombinant Sendai virus expressing the G glycoprotein of respiratory syncytial virus (RSV) elicits immune protection against RSV.

artículo científico publicado en 2004

Respiratory syncytial virus (RSV) fusion protein expressed by recombinant Sendai virus elicits B-cell and T-cell responses in cotton rats and confers protection against RSV subtypes A and B

artículo científico publicado en 2007

SHIV infection protects against heterologous pathogenic SHIV challenge in macaques: a gold-standard for HIV-1 vaccine development?

scientific article published on September 2009

Sendai virus recombinant vaccine expressing a secreted, unconstrained respiratory syncytial virus fusion protein protects against RSV in cotton rats

artículo científico publicado en 2014

Sendai virus recombinant vaccine expressing hPIV-3 HN or F elicits protective immunity and combines with a second recombinant to prevent hPIV-1, hPIV-3 and RSV infections

scientific article published on May 2008

UV-inactivated vaccinia virus (VV) in a multi-envelope DNA-VV-protein (DVP) HIV-1 vaccine protects macaques from lethal challenge with heterologous SHIV ⬇️

artículo científico publicado el 14 de marzo de 2012

Lista de obras de

A Multi-Vector, Multi-Envelope HIV-1 Vaccine

A rodent model of traumatic stress induces lasting sleep and quantitative electroencephalographic disturbances

CD8+ T-cells: are they sufficient to prevent, contain or eradicate HIV-1 infection?

Clade, Country and Region-specific HIV-1 Vaccines: Are they necessary?

Clustering of Th Cell Epitopes on Exposed Regions of HIV Envelope Despite Defects in Antibody Activity ⬇️

Discovery and Optimization of Potent and CNS Penetrant M5-Preferring Positive Allosteric Modulators Derived from a Novel, Chiral N-(Indanyl)piperidine Amide Scaffold

Discovery and optimization of 3-(4-aryl/heteroarylsulfonyl)piperazin-1-yl)-6-(piperidin-1-yl)pyridazines as novel, CNS penetrant pan-muscarinic antagonists.

Discovery of a novel 2,4-dimethylquinoline-6-carboxamide M4 positive allosteric modulator (PAM) chemotype via scaffold hopping

Discovery of a novel, CNS penetrant M4 PAM chemotype based on a 6-fluoro-4-(piperidin-1-yl)quinoline-3-carbonitrile core

Epstein-Barr virus vaccine development: a lytic and latent protein cocktail

Genetic analyses of gene function and pathogenesis of murine cytomegalovirus by transposon-mediated mutagenesis

Gle1 functions during mRNA export in an oligomeric complex that is altered in human disease

HIV vaccine rationale, design and testing.

HIV vaccines: brief review and discussion of future directions.

HIV-1 envelope T cell epitope "hotspots " among mice and humans and among CD4+ and CD8+ T cell subpopulations

HIV-1 vaccine development: tackling virus diversity with a multi-envelope cocktail.

Human PIV-2 recombinant Sendai virus (rSeV) elicits durable immunity and combines with two additional rSeVs to protect against hPIV-1, hPIV-2, hPIV-3, and RSV.

In vitro and in vivo characterization of a murine cytomegalovirus with a mutation at open reading frame m166.

Inhibition of ex vivo-expanded cytotoxic T-lymphocyte function by high-dose cyclosporine

Minor components of a multi-envelope HIV vaccine are recognized by type-specific T-helper cells

Multi-envelope HIV-1 vaccine devoid of SIV components controls disease in macaques challenged with heterologous pathogenic SHIV.

Multiple mycobacterial antigens are targets of the adaptive immune response in pulmonary sarcoidosis ⬇️

Murine cytomegalovirus with a transposon insertional mutation at open reading frame M35 is defective in growth in vivo

Murine cytomegalovirus with a transposon insertional mutation at open reading frame m155 is deficient in growth and virulence in mice

Partial mGlu₅ Negative Allosteric Modulators Attenuate Cocaine-Mediated Behaviors and Lack Psychotomimetic-Like Effects

Recombinant Sendai virus as a novel vaccine candidate for respiratory syncytial virus

Recombinant Sendai virus expressing the G glycoprotein of respiratory syncytial virus (RSV) elicits immune protection against RSV.

Respiratory syncytial virus (RSV) fusion protein expressed by recombinant Sendai virus elicits B-cell and T-cell responses in cotton rats and confers protection against RSV subtypes A and B

SHIV infection protects against heterologous pathogenic SHIV challenge in macaques: a gold-standard for HIV-1 vaccine development?

Sendai virus recombinant vaccine expressing a secreted, unconstrained respiratory syncytial virus fusion protein protects against RSV in cotton rats

Sendai virus recombinant vaccine expressing hPIV-3 HN or F elicits protective immunity and combines with a second recombinant to prevent hPIV-1, hPIV-3 and RSV infections

UV-inactivated vaccinia virus (VV) in a multi-envelope DNA-VV-protein (DVP) HIV-1 vaccine protects macaques from lethal challenge with heterologous SHIV ⬇️